Formulation of microneedles coated with influenza virus-like particle vaccine

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1193-1201

  Kim, Yeu Chun ^a,b   Quan, Fu Shi ^b   Compans, Richard W ^b   Kang, Sang Moo ^b   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coating formulation; influenza; intradermal immunization; microneedle; virus like particle vaccine

Indexed keywords

CARBOHYDRATE; CARBOXYMETHYLCELLULOSE; INFLUENZA VACCINE; TREHALOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MOUSE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SKIN PERMEABILITY; VIRUS HEMAGGLUTINATION; VIRUS LIKE AGENT; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; BANDAGES; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NEEDLES; TREATMENT OUTCOME; VACCINES, VIRUS-LIKE PARTICLE;

EID: 78649905693     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9471-3     Document Type: Article

References (43)

1. AH Ellebedy RJ Webby 2009 Influenza vaccines Vaccine 27 D65 8 1:CAS:528:DC%2BD1MXht1Ogtb7F 10.1016/j.vaccine.2009.08.038 19837290
2. M Hoelscher S Gangappa WM Zhong L Jayashankar S Sambhara 2008 Vaccines against epidemic and pandemic influenza Expert Opin Drug Deliv 5 1139 57 1:CAS:528:DC%2BD1cXhtFKhtrzP 10.1517/17425247.5.10.1139 18817518
3. KL Nichol JJ Treanor 2006 Vaccines for seasonal and pandemic influenza J Infect Dis 194 S111 8 10.1086/507544 17163383 (Pubitemid 44630954)
4. C Gerdil 2003 The annual production cycle for influenza vaccine Vaccine 21 1776 9 10.1016/S0264-410X(03)00071-9 12686093 (Pubitemid 36398372)
5. Centers for Disease Control and Prevention 2009 Use of influenza A (H1N1) 2009 monovalent vaccine, recommendations of the Advisory Committee on Immunization Practices Morb Mort Wkly Rep 58 1 8
6. KG Nicholson JM Wood M Zambon 2003 Influenza Lancet 362 1733 45 1:CAS:528:DC%2BD3sXpt1ShtL4%3D 10.1016/S0140-6736(03)14854-4 14643124 (Pubitemid 37468326)
7. AM Palache 1997 Influenza vaccines-a reappraisal of their use Drugs 54 841 56 1:STN:280:DyaK1c%2FotlCksg%3D%3D 10.2165/00003495-199754060-00004 9421692
8. GT Jennings MF Bachmann 2008 Coming of age of virus-like particle vaccines Biol Chem 389 521 36 1:CAS:528:DC%2BD1cXls1ait78%3D 10.1515/BC.2008.064 18953718 (Pubitemid 351874198)
9. R Noad P Roy 2003 Virus-like particles as immunogens Trends Microbiol 11 438 44 1:CAS:528:DC%2BD3sXnt1ylu70%3D 10.1016/S0966-842X(03)00208-7 13678860 (Pubitemid 37101484)
10. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009:369-93.
11. JA Matriano M Cormier J Johnson WA Young M Buttery K Nyam, et al. 2002 Macroflux (R) microprojection array patch technology: a new and efficient approach for intracutaneous immunization Pharm Res 19 63 70 1:CAS:528: DC%2BD38XhtVSmsbg%3D 10.1023/A:1013607400040 11837701 (Pubitemid 34075108)
12. AK Andrianov DP DeCollibus HA Gillis HH Kha A Marin MR Prausnitz, et al. 2009 Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization Proc Natl Acad Sci USA 106 18936 41 1:CAS:528:DC%2BD1MXhsFGqsrnJ 10.1073/pnas.0908842106 19864632
13. YC Kim FS Quan DG Yoo RW Compans SM Kang MR Prausnitz 2010 Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles J Infect Dis 201 190 8 1:CAS:528: DC%2BC3cXhvFSmsr0%3D 10.1086/649228 20017632
14. DG Koutsonanos MdP Martin VG Zarnitsyn SP Sullivan RW Compans MR Prausnitz, et al. 2009 Transdermal influenza immunization with vaccine-coated microneedle arrays PLoS ONE 4 e4773 10.1371/journal.pone.0004773 19274084
15. QY Zhu VG Zarnitsyn L Ye ZY Wen YL Gao L Pan, et al. 2009 Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge Proc Natl Acad Sci USA 106 7968 73 1:CAS:528:DC%2BD1MXmt1amt74%3D 10.1073/pnas.0812652106 19416832
16. P Van Damme F Oosterhuis-Kafeja M Van der Wielen Y Almagor O Sharon Y Levin 2009 Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults Vaccine 27 454 9 10.1016/j.vaccine.2008.10.077 19022318
17. JA Mikszta JB Alarcon JM Brittingham DE Sutter RJ Pettis NG Harvey 2002 Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery Nat Med 8 415 9 1:CAS:528: DC%2BD38XivVGls7k%3D 10.1038/nm0402-415 11927950 (Pubitemid 34407039)
18. C Debenedictis S Joubeh GY Zhang M Barria RF Ghohestani 2001 Immune functions of the skin Clin Dermatol 19 573 85 1:STN:280:DC%2BD3MrlslynsA%3D%3D 10.1016/S0738-081X(00)00173-5 11604304 (Pubitemid 32927173)
19. P Auewarakul U Kositanont P Sornsathapornkul P Tothong R Kanyok P Thongcharoen 2007 Antibody responses after dose-sparing intradermal influenza vaccination Vaccine 25 659 63 1:CAS:528:DC%2BD28Xht12rurfM 10.1016/j.vaccine. 2006.08.026 17011678 (Pubitemid 44856109)
20. RB Belshe FK Newman J Cannon C Duane J Treanor C Van Hoecke, et al. 2004 Serum antibody responses after intradermal vaccination against influenza New Engl J Med 351 2286 94 1:CAS:528:DC%2BD2cXhtValtr7I 10.1056/NEJMoa043555 15525713 (Pubitemid 39552744)
21. RT Kenney SA Frech LR Muenz CP Villar GM Glenn 2004 Dose sparing with intradermal injection of influenza vaccine New Engl J Med 351 2295 301 1:CAS:528:DC%2BD2cXhtValtr7J 10.1056/NEJMoa043540 15525714 (Pubitemid 39552745)
22. AR Hinman WA Orenstein JM Santoli LE Rodewald SL Cochi 2006 Vaccine shortages: history, impact, and prospects for the future Annu Rev Public Health 27 235 59 10.1146/annurev.publhealth.27.021405.102248 16533116
23. D Holland R Booy F De Looze P Eizenberg J McDonald J Karrasch, et al. 2008 Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial J Infect Dis 198 650 8 10.1086/590434 18652550
24. PH Lambert PE Laurent 2008 Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26 3197 208 1:CAS:528:DC%2BD1cXnt1SmtLc%3D 10.1016/j.vaccine.2008.03.095 18486285
25. YC Kim FS Quan DG Yoo RW Compans SM Kang MR Prausnitz 2009 Improved influenza vaccination in the skin using vaccine coated-microneedles Vaccine 27 6932 8 1:CAS:528:DC%2BD1MXhtlCmsLzM 10.1016/j.vaccine.2009.08.108 19761836
26. FS Quan YC Kim DG Yoo RW Compans MR Prausnitz SM Kang 2009 Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin PLoS ONE 4 e7152 10.1371/journal.pone.0007152 19779615
27. SM Bal J Caussin S Pavel JA Bouwstra 2008 In vivo assessment of safety of microneedle arrays in human skin Eur J Pharm Sci 35 193 202 1:CAS:528:DC%2BD1cXhtVyltrzK 10.1016/j.ejps.2008.06.016 18657610
28. HS Gill DD Denson BA Burris MR Prausnitz 2008 Effect of microneedle design on pain in human volunteers Clin J Pain 24 585 94 10.1097/AJP. 0b013e31816778f9 18716497
29. MI Haq E Smith DN John M Kalavala C Edwards A Anstey, et al. 2008 Clinical administration of microneedles: skin puncture, pain and sensation Biomed Microdevices 11 35 47 10.1007/s10544-008-9208-1
30. FS Quan CZ Huang RW Compans SM Kang 2007 Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus J Virol 81 3514 24 1:CAS:528:DC%2BD2sXjslWqsLw%3D 10.1128/JVI.02052-06 17251294 (Pubitemid 46456660)
31. K Ludwig T Korte A Herrmann 1995 Analysis of delay times of hemagglutinin-mediated fusion between influenza-virus and cell-membranes Eur Biophys J 24 55 64 1:STN:280:DyaK28%2FntlWhtQ%3D%3D 10.1007/BF00211399 8582319
32. HS Gill MR Prausnitz 2007 Coated microneedles for transdermal delivery J Control Release 117 227 37 1:CAS:528:DC%2BD2sXht1Cmsbs%3D 10.1016/j.jconrel. 2006.10.017 17169459 (Pubitemid 46161873)
33. YC Kim FS Quan RW Compans SM Kang MR Prausnitz 2010 Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity J Control Release 142 187 95 1:CAS:528: DC%2BC3cXhvFehuro%3D 10.1016/j.jconrel.2009.10.013 19840825
34. GN Vyas NR Shulman 1970 Hemagglutination assay for antigen and antibody associated with viral hepatitis Science 170 332 3 1:STN:280:DyaE3c3psVeltQ%3D%3D 10.1126/science.170.3955.332 4990052
35. I Skountzou FS Quan J Jacob RW Compans SM Kang 2006 Transcutaneous immunization with inactivated influenza virus induces protective immune responses Vaccine 24 6110 9 1:CAS:528:DC%2BD28XotV2ntb0%3D 10.1016/j.vaccine. 2006.05.014 16766095 (Pubitemid 44175614)
36. XF Chen TW Prow ML Crichton DWK Jenkins MS Roberts IH Frazer, et al. 2009 Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin J Control Release 139 212 20 1:CAS:528: DC%2BD1MXhtFOkt7bO 10.1016/j.jconrel.2009.06.029 19577597
37. FS Quan D Steinhauer C Huang TM Ross RW Compans S-M Kang 2008 A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs Vaccine 26 3352 61 1:CAS:528:DC%2BD1cXnt1Smurg%3D 10.1016/j.vaccine.2008.03.055 18468740
38. JP Amorij A Huckriede J Wischut HW Frifflink WLJ Hinrichs 2008 Development of stable influenza vaccine powder formulations: challenges and possibilities Pharm Res 25 1256 73 1:CAS:528:DC%2BD1cXltFCjsbo%3D 10.1007/s11095-008-9559-6 18338241
39. FS Quan RW Compans HH Nguyen SM Kang 2008 Induction of heterosubtypic immunity to influenza virus by intranasal immunization J Virol 82 1350 9 1:CAS:528:DC%2BD1cXhtFOktb0%3D 10.1128/JVI.01615-07 18032492
40. JP Amorij J Meulenaar WLJ Hinrichs T Stegmann A Huckriede F Coenen, et al. 2007 Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze drying Vaccine 25 6447 57 1:CAS:528:DC%2BD2sXovFOjtbg%3D 10.1016/j.vaccine.2007.06.054 17673338 (Pubitemid 47198923)
41. J de Jonge JP Amorij WLJ Hinrichs J Wiischuta A Huckriedea HW Frijlinkb 2007 Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage Eur J Pharm Sci 32 33 44 10.1016/j.ejps.2007.05.112 17628452 (Pubitemid 47102189)
42. YF Maa M Ameri C Shu LG Payne DX Chen 2004 Influenza vaccine powder formulation development: spray freeze drying and stability evaluation J Pharm Sci 93 1912 23 1:CAS:528:DC%2BD2cXltlKrsL8%3D 10.1002/jps.20104 15176078 (Pubitemid 38823716)
43. DA Steinhauer 1999 Role of hemagglutinin cleavage for the pathogenicity of influenza virus Virology 258 1 20 1:CAS:528:DyaK1MXivFOqt7s%3D 10.1006/viro.1999.9716 10329563 (Pubitemid 29391776)